The Hemiplegia Market was valued at USD 3.5 billion in 2024 and is projected to reach USD 7.2 billion by 2034, registering a CAGR of 7.5%. This growth trajectory is underpinned by several factors, including the rising incidence of neurological disorders, advancements in rehabilitation technologies, and increasing awareness regarding hemiplegia management. The demand for effective treatment...